<DOC>
	<DOC>NCT00186069</DOC>
	<brief_summary>To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption.</brief_summary>
	<brief_title>Magnesium Sulfate vs Placebo for Placental Abruption</brief_title>
	<detailed_description>We hope to learn if there is a difference in the efficacy of intravenous magnesium sulfate versus intravenous saline infusion in the resolution of vaginal bleeding and contractions in patients with a suspected placental abruption.</detailed_description>
	<mesh_term>Abruptio Placentae</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>vaginal bleeding and contractions consistent with suspected placental abruption between 24 and 34 weeks gestation. preterm labor, severe bleeding necessitating immediate delivery, maternal coagulopathy, fetal distress</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>